513 related articles for article (PubMed ID: 9569186)
1. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
2. Increased thromboxane biosynthesis in essential thrombocythemia.
Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
[TBL] [Abstract][Full Text] [Related]
3. Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo".
Landolfi R; De Candia E; Rocca B; Ciabattoni G; Antinori A; Masetti R; Patrono C
Thromb Haemost; 1994 Dec; 72(6):942-6. PubMed ID: 7740468
[TBL] [Abstract][Full Text] [Related]
4. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
7. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
Davì G; Basili S; Vieri M; Cipollone F; Santarone S; Alessandri C; Gazzaniga P; Cordova C; Violi F
Am J Respir Crit Care Med; 1997 Dec; 156(6):1794-9. PubMed ID: 9412557
[TBL] [Abstract][Full Text] [Related]
8. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C
Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2 biosynthesis in human disease.
FitzGerald GA; Healy C; Daugherty J
Fed Proc; 1987 Jan; 46(1):154-8. PubMed ID: 3100340
[TBL] [Abstract][Full Text] [Related]
10. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
Milani M; Cimminiello C; Lorena M; Arpaia G; Soncini M; Bonfardeci G
Biomed Pharmacother; 1996; 50(6-7):269-74. PubMed ID: 8952866
[TBL] [Abstract][Full Text] [Related]
11. Paired analysis of urinary thromboxane B2 metabolites in humans.
Catella F; FitzGerald GA
Thromb Res; 1987 Sep; 47(6):647-56. PubMed ID: 3686481
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites.
Forastiero R; Martinuzzo M; Carreras LO; Maclouf J
Thromb Haemost; 1998 Jan; 79(1):42-5. PubMed ID: 9459320
[TBL] [Abstract][Full Text] [Related]
14. Defective aggregation in cirrhosis is independent of in vivo platelet activation.
Laffi G; Cinotti S; Filimberti E; Ciabattoni G; Caporale R; Marra F; Melani L; Grossi A; Carloni V; Gentilini P
J Hepatol; 1996 Apr; 24(4):436-43. PubMed ID: 8738730
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R
Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910
[TBL] [Abstract][Full Text] [Related]
16. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
17. Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.
Di Minno G; Davì G; Margaglione M; Cirillo F; Grandone E; Ciabattoni G; Catalano I; Strisciuglio P; Andria G; Patrono C
J Clin Invest; 1993 Sep; 92(3):1400-6. PubMed ID: 8376592
[TBL] [Abstract][Full Text] [Related]
18. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
Christman BW; McPherson CD; Newman JH; King GA; Bernard GR; Groves BM; Loyd JE
N Engl J Med; 1992 Jul; 327(2):70-5. PubMed ID: 1603138
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane B2 urinary metabolites in patients undergoing cardiopulmonary bypass.
Jörres A; Chiabrando C; Kordonouri O; Schiessler A; Hess S; Farke S; Gahl GM; Müller C; Rivoltella L; Djurup R
Eicosanoids; 1992; 5(3-4):147-51. PubMed ID: 1292525
[TBL] [Abstract][Full Text] [Related]
20. [Urinary 11-dehydro thromboxane B2 during toxemic pregnancies].
Kobayashi S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):715-21. PubMed ID: 1890349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
